Won‐Mook Choi

2.0k total citations
71 papers, 1.2k citations indexed

About

Won‐Mook Choi is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Won‐Mook Choi has authored 71 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hepatology, 42 papers in Epidemiology and 10 papers in Oncology. Recurrent topics in Won‐Mook Choi's work include Liver Disease Diagnosis and Treatment (39 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers) and Hepatitis B Virus Studies (24 papers). Won‐Mook Choi is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers) and Hepatitis B Virus Studies (24 papers). Won‐Mook Choi collaborates with scholars based in South Korea, United States and Hong Kong. Won‐Mook Choi's co-authors include Young‐Suk Lim, Jonggi Choi, Won‐Il Jeong, Kang Mo Kim, Hyuk Soo Eun, Jun Hee Lee, Ju Hyun Shim, Han Chu Lee, Danbi Lee and Wonhyo Seo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Won‐Mook Choi

65 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Won‐Mook Choi South Korea 20 646 612 231 135 135 71 1.2k
Joeri Lambrecht Germany 15 560 0.9× 430 0.7× 251 1.1× 187 1.4× 158 1.2× 26 1.0k
Jinhua Hu China 20 400 0.6× 467 0.8× 349 1.5× 92 0.7× 190 1.4× 99 1.2k
Jana C. Mossanen Germany 13 662 1.0× 557 0.9× 304 1.3× 442 3.3× 126 0.9× 22 1.5k
David E. Smart United Kingdom 14 314 0.5× 371 0.6× 260 1.1× 101 0.7× 129 1.0× 24 910
Hyuk Soo Eun South Korea 20 420 0.7× 278 0.5× 460 2.0× 282 2.1× 215 1.6× 68 1.3k
Yun Bin Lee South Korea 25 922 1.4× 956 1.6× 406 1.8× 69 0.5× 170 1.3× 105 1.8k
Kenichiro Mikami Japan 17 363 0.6× 303 0.5× 267 1.2× 84 0.6× 42 0.3× 38 823
Jinzheng Li China 15 317 0.5× 219 0.4× 333 1.4× 243 1.8× 120 0.9× 50 939
Xuehua Sun China 17 245 0.4× 186 0.3× 338 1.5× 222 1.6× 123 0.9× 49 877
Zhiren Fu China 17 263 0.4× 313 0.5× 266 1.2× 115 0.9× 177 1.3× 63 934

Countries citing papers authored by Won‐Mook Choi

Since Specialization
Citations

This map shows the geographic impact of Won‐Mook Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won‐Mook Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won‐Mook Choi more than expected).

Fields of papers citing papers by Won‐Mook Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won‐Mook Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won‐Mook Choi. The network helps show where Won‐Mook Choi may publish in the future.

Co-authorship network of co-authors of Won‐Mook Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Won‐Mook Choi. A scholar is included among the top collaborators of Won‐Mook Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won‐Mook Choi. Won‐Mook Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hui, Rex Wan‐Hin, Byeong Geun Song, In Hye Song, et al.. (2025). Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma. Alimentary Pharmacology & Therapeutics. 61(10). 1680–1691.
2.
Chung, Sung Won, Jin Sun Kim, Won‐Mook Choi, et al.. (2025). Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma. Clinical Cancer Research. 31(10). 2046–2055. 1 indexed citations
3.
Park, Hyo Jung, Dong Wook Kim, Won‐Mook Choi, & So Yeon Kim. (2025). Abbreviated MRI-Based Surveillance Strategies for Early Hepatocellular Carcinoma Detection. PubMed. 86(3). 335–335. 1 indexed citations
4.
Lee, Hye Won, Won‐Mook Choi, Danbi Lee, et al.. (2025). Risk of Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab Treatment for Hepatocellular Carcinoma. Alimentary Pharmacology & Therapeutics. 61(8). 1310–1317.
5.
Chung, Sung Won, Ye‐Jee Kim, Jonggi Choi, et al.. (2024). Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study. The American Journal of Gastroenterology. 120(10). 2302–2311.
6.
Choi, Jonggi, Won‐Mook Choi, Danbi Lee, et al.. (2024). Improving the hepatitis C virus care cascade with the in‐hospital Reflex tEsting ALarm‐C (REAL‐C) model. Liver International. 44(5). 1243–1252.
7.
Choi, Won‐Mook, Danbi Lee, Ju Hyun Shim, et al.. (2024). Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma. SHILAP Revista de lepidopterología. 24(2). 178–191. 1 indexed citations
8.
Yang, Jiwon, Won‐Mook Choi, Ju Hyun Shim, et al.. (2024). Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability. Journal of Gastroenterology and Hepatology. 39(10). 2112–2119. 2 indexed citations
9.
Choi, Jonggi, Won‐Mook Choi, & Young‐Suk Lim. (2023). Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?. Clinics in Liver Disease. 27(4). 809–818. 1 indexed citations
10.
Choi, Won‐Mook, Ju Hyun Shim, Danbi Lee, et al.. (2023). Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment. SHILAP Revista de lepidopterología. 23(1). 177–188. 6 indexed citations
11.
Choi, Won‐Mook, Seungbong Han, Young Seok Kim, et al.. (2023). A model for predicting poor survival in patients with cirrhosis undergoing portosystemic shunt embolization. Journal of Gastroenterology and Hepatology. 38(9). 1629–1636. 2 indexed citations
12.
Choi, Won‐Mook, Ju Hyun Shim, Kang Mo Kim, et al.. (2023). Prediction of Hepatocellular Carcinoma Development in Korean Patients after Hepatitis C Cure with Direct-Acting Antivirals. Gut and Liver. 18(1). 147–155. 4 indexed citations
13.
Choi, Won‐Mook, Danbi Lee, Ju Hyun Shim, et al.. (2023). Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment. Alimentary Pharmacology & Therapeutics. 59(4). 515–525. 6 indexed citations
14.
Choi, Won‐Mook, Gi‐Ae Kim, Jonggi Choi, et al.. (2023). Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B. Gut. 73(4). 649–658. 17 indexed citations
15.
Choi, Won‐Mook, Ju Hyun Shim, Danbi Lee, et al.. (2022). Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis B. Liver International. 42(7). 1517–1527. 26 indexed citations
16.
Choi, Won‐Mook, Ji Yoon Kim, Jonggi Choi, et al.. (2021). Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma. Liver International. 41(9). 2189–2199. 28 indexed citations
17.
Choi, Won‐Mook, Terry Cheuk‐Fung Yip, Young‐Suk Lim, Grace Lai–Hung Wong, & W. Ray Kim. (2021). Methodological challenges of performing meta-analyses to compare the risk of hepatocellular carcinoma between chronic hepatitis B treatments. Journal of Hepatology. 76(1). 186–194. 21 indexed citations
18.
Choi, Won‐Mook, et al.. (2021). A risk scoring system to predict clinical events in chronic hepatitis B virus infection: A nationwide cohort study. Journal of Viral Hepatitis. 29(2). 115–123. 1 indexed citations
19.
Choi, Won‐Mook, et al.. (2021). Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population‐based study. Liver International. 41(11). 2777–2785. 20 indexed citations
20.
Choi, Won‐Mook, Jonggi Choi, Danbi Lee, et al.. (2020). Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma. Hepatology Communications. 4(7). 1073–1086. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026